SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-049199
Filing Date
2022-09-08
Accepted
2022-09-08 17:04:48
Documents
2
Period of Report
2022-09-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 12674
2 POA DOCUMENT poa.txt EX-24 3098
  Complete submission text file 0001209191-22-049199.txt   17170
Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Issuer) CIK: 0001671858 (see all company filings)

IRS No.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SILVERBACK THERAPEUTICS, INC. 500 FAIRVIEW AVENUE N, SUITE 600 SEATTLE WA 98109
Business Address
Pepe Jeffrey C. (Reporting) CIK: 0001943992 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39756 | Film No.: 221234403